Hansa Biopharma publishes Annual Report 2021 |
| April 07, 2022 | April 2022 Bond Updates |
|
LUND, Sweden, April 7, 2022 /PRNewswire/ -- Hansa Biopharma AB "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the Annual Report 2021 Søren Tulstrup, President and CEO of Hansa Biopharma, comments: 2021... |
| View more at: https://www.prnewswire.com:443/news-releases/hansa-biopharma-publishes-annual-report-2021-301519710.html |